Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 10:01 AM GMTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 6:00 AM GMTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
Medical Bulletin 17/November/2022 Dr. Nandita Mohan17 Nov 2022 11:30 AM GMTHere are the top medical news for the day:New nasal vaccine strategy could improve COVID-19 protectionCurrently many vaccines against SARS-CoV-2 have...
New nasal vaccine strategy could improve COVID-19 protection Dr. Nandita Mohan17 Nov 2022 3:30 AM GMTCurrently many vaccines against SARS-CoV-2 have substantially been found to reduce mortality and severe progression of the disease, but protection...
AIIMS Delhi to conduct trials of Bharat Biotech's nasal COVID vaccine: Report Medical Dialogues Bureau9 Sep 2021 3:45 AM GMTThe country's premier hospital and research centre, AIIMS will be starting trials of nasal COVID vaccine within a couple of weeks and an application...
